Long-term upper airway changes following mandibular advancement with or without maxillary setback in skeletal class II patients: a 2-year retrospective study

骨性II类错颌患者下颌前移(伴或不伴上颌后退)后上呼吸道长期变化:一项为期2年的回顾性研究

阅读:1

Abstract

OBJECTIVE: This study assessed 2-year oropharyngeal airway changes in skeletal Class II patients following isolated mandibular advancement by bilateral sagittal split osteotomy (BSSO) with or without maxillary setback by Le Fort I osteotomy (Le fort I). MATERIALS AND METHODS: Cone-beam computed tomography (CBCT) data from 25 isolated BSSO and 57 BSSO + Le fort I patients were retrospectively analyzed at three stages: preoperatively (T0), 3 months (T1), and 2 years postoperatively (T2). The total upper airway volume (V), minimum cross-sectional area (CSA(min)), and volumes of the nasopharynx (V(NA)), velopharynx (V(VE)), and glossopharynx (V(GL)) were measured via Dolphin Imaging. RESULTS: Isolated BSSO significantly increased V, CSA(min), V(NA), V(VE), and V(GL) by 38.86%, 69.49%, 22.31%, 46.05%, and 46.94%, respectively, at T1 (P < 0.01) and 21.85%, 43.11%, 13.85%, 19.73%, and 25.38%, respectively, at T2 (P < 0.05). From T1 to T2, V, CSA(min), V(VE), and V(GL) decreased by 12.24%, 15.56%, 18.02%, and 14.67%, respectively (P < 0.05). Multivariate regression revealed that each 1 mm advancement of the PNS and B points increased V by 1038 mm³ and V(VE) by 519 mm³; PNS advancement increased V(NA) by 708 mm³ (P < 0.05). Compared with BSSO + Le fort I, isolated BSSO yielded greater short-term improvements (V: +11175 vs. +3638 mm³; P < 0.001) and superior long-term stability in V and V(NA) (P < 0.05). Notably, the combined advancement of PNS and B point may be a robust predictor for postoperative changes of the upper airway volume. CONCLUSION: Isolated BSSO induces sustained upper airway expansion for 2 years, which is driven primarily by hard tissue advancements. Compared with BSSO + Le fort I, this technique has superior short- and long-term efficacy, providing guidance for the optimized management of skeletal Class II patients. ETHICS APPROVAL: This study was approved by the Ethics Committee of Peking University Stomatological Hospital (Approval No. PKUSSIRB-202167121).

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。